Read Time:13 Second
Eli Lilly said Friday that it has applied for U.S. regulatory approval to expand the use of its weight-loss drug Zepbound to include treatment of sleep apnea, as new data show the drug may help many people breathe easier at night.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
